Sanofi Pays Regeneron Up to $8 Billion to Expand Immunology Alliance
The pharmaceutical firms are re-upping their collaboration pact to co-develop four next-generation antibody drug candidates following the success of Dupixent.
The story so far
2 publishers have covered this in 3 articles since 1 Oct 2026. STAT published first, on 1 October at 06:16 UTC; Quartz followed 30h 14m later. The most recent article, from Quartz, appeared on 2 October at 12:30 UTC.
Outlets reporting it: STAT, Quartz.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Sanofi
- Regeneron